Ozempic lists for roughly $969 in the United States and around €59 in Germany — the same pen, the same molecule, made in the same Danish factory. The reason winds back to a Nobel laureate's 1922 trip ...
Eisai and Biogen have completed their rolling biologics license application in the US for a subcutaneous formulation of Alzheimer's disease therapy Leqembi previously delayed by the FDA on procedural ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results